The PGRN/p-tau ratio was better at differentiating AD from FTLD-tau (Fig. 4a) and FTLD-TDP and FTLD-tau from prion disease and DLB (Fig. 4b) than p-tau alone (Fig. 1e). The gene discussed is MAPT; the disease is Alzheimer disease.